Doxazosina Eurofarma

Doxazosina Eurofarma is a pharmaceutical product containing doxazosin mesylate, primarily used to treat hypertension (high blood pressure) and symptoms of Benign Prostatic Hyperplasia (BPH). It is manufactured by Eurofarma Laboratórios S.A., a major Brazilian multinational pharmaceutical corporation. Founded in 1972 by Italian immigrants Galliano and Maria Teresa Billi, the company has grown into one of Latin America's largest medicine producers.

While its primary manufacturing hub is located in Brazil (notably in the Itapevi Complex in São Paulo), Eurofarma maintains a significant industrial presence across 20 countries, including factories in Argentina, Colombia, Chile, and Mexico. The brand remains under the control of the founding Billi family, maintaining its status as a 100% Brazilian-capital multinational despite its extensive international reach and recent acquisitions like Genfar in Colombia.